Mitrašinović, Petar M.

Link to this page

Authority KeyName Variants
orcid::0000-0002-0987-4893
  • Mitrašinović, Petar M. (6)
Projects

Author's Bibliography

Computational investigations of the binding mechanism of current influenza virus neuraminidase inhibitors: Correlation with experiment

Mihajlović, M.L.; Mitrašinović, Petar M.

(Nova Science Publishers, Inc., 2009)

TY  - CHAP
AU  - Mihajlović, M.L.
AU  - Mitrašinović, Petar M.
PY  - 2009
UR  - https://ritnms.itnms.ac.rs/handle/123456789/167
AB  - In the context of the recent pandemic threat by the worldwide spread of H5N1 avian influenza, novel insights into the mechanisms of ligand binding and interaction between various inhibitors (zanamivir-ZMV, oseltamivir-OTV, DANA, peramivir-PMV) and neuraminidases (NAs) are of vital importance for the structure-based design of new antiviral drugs. Computational methods are herein shown to be a viable partner to experiment in the investigation of the binding modes of known NA inhibitors. Using the crystal structures of inhibitors bound to either group-2 or group-1 NAs, the AScore/ShapeDockscoring was shown to identify the binding modes in agreement with the experiment for all inhibitors docked in their own NA/inhibitor crystal structures. To investigate the effect of small changes in protein structure on predicted binding modes, in a set of 132 docking experiments (11 inhibitors docked in 12 group-2 NA structures) AScore/ShapeDock identified the correct binding modes of 116 complexes. In a total of 88 docking experiments (8 inhibitors docked in 11 group-1 NA structures) AScore/ShapeDock predicted 80 binding modes correctly. A small vHTS experiment, reflected by mixing the known activity molecules to a set of randomly selected molecules, confirmed the ability of the AScore/ShapeDock approach to extract biologically active molecules from inactive ones. By both outperforming other docking methods used previously in the literature and being quite reproducible, the AScore/ShapeDock protocol is suggested to be convenient for designing novel H5N1-NA inhibitors. To shed more light on the high resistance of H5N1 strains to various NA inhibitors, the three-dimensional models of H5N1-NA andN9-NA were generated by homology modeling. Traditional residues within the active site throughout the family of NA protein structures were found to be highly conserved in H5N1-NA, and a subtle variation between lipophilic and hydrophilic environments in H5N1-NA with respect to N9-NA was observed. Besides, molecular bases of the mechanism of H5N1-NA resistance to oseltamivir were elucidated in a systematic fashion. Using the crystal structure of the complex of H5N1-NA with OTV (PDB ID: 2hu0) as the starting point, the following question was addressed and correlated with the experimental data: How mutations at His274 by both smaller side chain (Gly, Ser, Asn, Gln) and larger side chain (Phe, Tyr) residues influence the sensitivity of N1 to oseltamivir? The smaller side chain residue mutations of His274 resulted in slightly enhanced or unchanged NA sensitivity to OTV, while His274Phe and His274Tyr reduced the susceptibility of OTV to N1. In contrast to the binding free energies, the net charges of Glu276 and Arg224, making charge-charge interactions with Glu276, were established to be more sensitive to detecting subtle conformational differences induced at the key residue Glu276 by the His274X mutations. Thus, deeper insights into the possibility of developing viable drug-resistant mutants were possible.
PB  - Nova Science Publishers, Inc.
T2  - Global View of the Fight Against Influenza
T1  - Computational investigations of the binding mechanism of current influenza virus neuraminidase inhibitors: Correlation with experiment
EP  - 153
SP  - 119
UR  - conv_1091
ER  - 
@inbook{
author = "Mihajlović, M.L. and Mitrašinović, Petar M.",
year = "2009",
abstract = "In the context of the recent pandemic threat by the worldwide spread of H5N1 avian influenza, novel insights into the mechanisms of ligand binding and interaction between various inhibitors (zanamivir-ZMV, oseltamivir-OTV, DANA, peramivir-PMV) and neuraminidases (NAs) are of vital importance for the structure-based design of new antiviral drugs. Computational methods are herein shown to be a viable partner to experiment in the investigation of the binding modes of known NA inhibitors. Using the crystal structures of inhibitors bound to either group-2 or group-1 NAs, the AScore/ShapeDockscoring was shown to identify the binding modes in agreement with the experiment for all inhibitors docked in their own NA/inhibitor crystal structures. To investigate the effect of small changes in protein structure on predicted binding modes, in a set of 132 docking experiments (11 inhibitors docked in 12 group-2 NA structures) AScore/ShapeDock identified the correct binding modes of 116 complexes. In a total of 88 docking experiments (8 inhibitors docked in 11 group-1 NA structures) AScore/ShapeDock predicted 80 binding modes correctly. A small vHTS experiment, reflected by mixing the known activity molecules to a set of randomly selected molecules, confirmed the ability of the AScore/ShapeDock approach to extract biologically active molecules from inactive ones. By both outperforming other docking methods used previously in the literature and being quite reproducible, the AScore/ShapeDock protocol is suggested to be convenient for designing novel H5N1-NA inhibitors. To shed more light on the high resistance of H5N1 strains to various NA inhibitors, the three-dimensional models of H5N1-NA andN9-NA were generated by homology modeling. Traditional residues within the active site throughout the family of NA protein structures were found to be highly conserved in H5N1-NA, and a subtle variation between lipophilic and hydrophilic environments in H5N1-NA with respect to N9-NA was observed. Besides, molecular bases of the mechanism of H5N1-NA resistance to oseltamivir were elucidated in a systematic fashion. Using the crystal structure of the complex of H5N1-NA with OTV (PDB ID: 2hu0) as the starting point, the following question was addressed and correlated with the experimental data: How mutations at His274 by both smaller side chain (Gly, Ser, Asn, Gln) and larger side chain (Phe, Tyr) residues influence the sensitivity of N1 to oseltamivir? The smaller side chain residue mutations of His274 resulted in slightly enhanced or unchanged NA sensitivity to OTV, while His274Phe and His274Tyr reduced the susceptibility of OTV to N1. In contrast to the binding free energies, the net charges of Glu276 and Arg224, making charge-charge interactions with Glu276, were established to be more sensitive to detecting subtle conformational differences induced at the key residue Glu276 by the His274X mutations. Thus, deeper insights into the possibility of developing viable drug-resistant mutants were possible.",
publisher = "Nova Science Publishers, Inc.",
journal = "Global View of the Fight Against Influenza",
booktitle = "Computational investigations of the binding mechanism of current influenza virus neuraminidase inhibitors: Correlation with experiment",
pages = "153-119",
url = "conv_1091"
}
Mihajlović, M.L.,& Mitrašinović, P. M.. (2009). Computational investigations of the binding mechanism of current influenza virus neuraminidase inhibitors: Correlation with experiment. in Global View of the Fight Against Influenza
Nova Science Publishers, Inc.., 119-153.
conv_1091
Mihajlović M, Mitrašinović PM. Computational investigations of the binding mechanism of current influenza virus neuraminidase inhibitors: Correlation with experiment. in Global View of the Fight Against Influenza. 2009;:119-153.
conv_1091 .
Mihajlović, M.L., Mitrašinović, Petar M., "Computational investigations of the binding mechanism of current influenza virus neuraminidase inhibitors: Correlation with experiment" in Global View of the Fight Against Influenza (2009):119-153,
conv_1091 .
1

Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study

Mihajlović, Marija; Mitrašinović, Petar M.

(Srpsko hemijsko društvo, Beograd, 2009)

TY  - JOUR
AU  - Mihajlović, Marija
AU  - Mitrašinović, Petar M.
PY  - 2009
UR  - https://ritnms.itnms.ac.rs/handle/123456789/153
AB  - In the context of the recent pandemic threat by the worldwide spread of H5N1 avian influenza, novel insights into the mechanism of ligand binding and interaction between various inhibitors (zanamivir - ZMV, oseltamivir - OTV, 2,3-didehydro-2-deoxy-N-acetylneuraminic acid - DANA, peramivir - PMV) and neuraminidases (NA) are of vital importance for the structure-based design of new anti-viral drugs. To address this issue, three-dimensional models of H5N1-NA and N9-NA were generated by homology modeling. Traditional residues within the active site throughout the family of NA protein structures were found to be highly conserved in H5N1-NA. A subtle variation between lipophilic and hydrophilic environments in H5N1-NA with respect to N9-NA was observed, thus shedding more light on the high resistance of some H5N1 strains to various NA inhibitors. Based on these models, an ArgusLab4/AScore flexible docking study was performed. The conformational differences between OTV bound to H5N1-NA and OTV bound to N9-NA were structurally identified and quantified. A slight difference of less than 1 kcal mol(-1) between the OTV-N9 and OTV-N1 binding free energies is in agreement with the experimentally predicted free energy difference. The conformational differences between ZMV and OTV bound to either H5N1-NA or N9-NA were structurally identified. The binding free energies of the ZMV complexes, being slightly higher than those of OTV, are not in agreement with what was previously proposed using homology modeling. The differences between-ZMV and OTV are suggested to be ascribed to the presence/absence of Asn 166 in the active cavity of ZMV/OTV in H5N1-NA, and to the presence/absence of Ser165 in the binding site of ZMV/OTV in N9-NA. The charge distribution was evaluated using the semi-empirical AMI method. The trends of the AMI charges of the ZMV and OTV side chains in the complexes deviate from those previously reported.
PB  - Srpsko hemijsko društvo, Beograd
T2  - Journal of the Serbian Chemical Society
T1  - Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study
EP  - 13
IS  - 1
SP  - 1
VL  - 74
DO  - 10.2298/JSC0901001M
UR  - conv_555
ER  - 
@article{
author = "Mihajlović, Marija and Mitrašinović, Petar M.",
year = "2009",
abstract = "In the context of the recent pandemic threat by the worldwide spread of H5N1 avian influenza, novel insights into the mechanism of ligand binding and interaction between various inhibitors (zanamivir - ZMV, oseltamivir - OTV, 2,3-didehydro-2-deoxy-N-acetylneuraminic acid - DANA, peramivir - PMV) and neuraminidases (NA) are of vital importance for the structure-based design of new anti-viral drugs. To address this issue, three-dimensional models of H5N1-NA and N9-NA were generated by homology modeling. Traditional residues within the active site throughout the family of NA protein structures were found to be highly conserved in H5N1-NA. A subtle variation between lipophilic and hydrophilic environments in H5N1-NA with respect to N9-NA was observed, thus shedding more light on the high resistance of some H5N1 strains to various NA inhibitors. Based on these models, an ArgusLab4/AScore flexible docking study was performed. The conformational differences between OTV bound to H5N1-NA and OTV bound to N9-NA were structurally identified and quantified. A slight difference of less than 1 kcal mol(-1) between the OTV-N9 and OTV-N1 binding free energies is in agreement with the experimentally predicted free energy difference. The conformational differences between ZMV and OTV bound to either H5N1-NA or N9-NA were structurally identified. The binding free energies of the ZMV complexes, being slightly higher than those of OTV, are not in agreement with what was previously proposed using homology modeling. The differences between-ZMV and OTV are suggested to be ascribed to the presence/absence of Asn 166 in the active cavity of ZMV/OTV in H5N1-NA, and to the presence/absence of Ser165 in the binding site of ZMV/OTV in N9-NA. The charge distribution was evaluated using the semi-empirical AMI method. The trends of the AMI charges of the ZMV and OTV side chains in the complexes deviate from those previously reported.",
publisher = "Srpsko hemijsko društvo, Beograd",
journal = "Journal of the Serbian Chemical Society",
title = "Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study",
pages = "13-1",
number = "1",
volume = "74",
doi = "10.2298/JSC0901001M",
url = "conv_555"
}
Mihajlović, M.,& Mitrašinović, P. M.. (2009). Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study. in Journal of the Serbian Chemical Society
Srpsko hemijsko društvo, Beograd., 74(1), 1-13.
https://doi.org/10.2298/JSC0901001M
conv_555
Mihajlović M, Mitrašinović PM. Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study. in Journal of the Serbian Chemical Society. 2009;74(1):1-13.
doi:10.2298/JSC0901001M
conv_555 .
Mihajlović, Marija, Mitrašinović, Petar M., "Some novel insights into the binding of oseltamivir and zanamivir to H5N1 and N9 influenza virus neuraminidases: a homology modeling and flexible docking study" in Journal of the Serbian Chemical Society, 74, no. 1 (2009):1-13,
https://doi.org/10.2298/JSC0901001M .,
conv_555 .
20
21
16

Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs)

Mihajlović, Marija; Mitrašinović, Petar M.

(Taylor & Francis Ltd, Abingdon, 2009)

TY  - JOUR
AU  - Mihajlović, Marija
AU  - Mitrašinović, Petar M.
PY  - 2009
UR  - https://ritnms.itnms.ac.rs/handle/123456789/147
AB  - Using the crystal structures of inhibitors bound to either group-2 or group-1 neuraminidases (NAs), AScore/ShapeDock (GaDock) scoring was shown to identify the binding modes in agreement with the experiment for all inhibitors docked in their own NA/inhibitor crystal structures. To investigate the effect of small changes in protein structure on predicted binding modes, in a set of 132 docking experiments (11 inhibitors docked in 12 group-2 NA structures), AScore/ShapeDock (GaDock) identified the correct binding modes of 116 complexes. In a total of 88 docking experiments (8 inhibitors docked in 11 group-1 NA structures), AScore/ShapeDock predicted 80 binding modes correctly. Flexible AScore/ShapeDock docking, as quite reproducible, is suggested to be convenient for designing novel H5N1 inhibitors.
PB  - Taylor & Francis Ltd, Abingdon
T2  - Molecular Simulation
T1  - Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs)
EP  - 324
IS  - 4
SP  - 311
VL  - 35
DO  - 10.1080/08927020802430752
UR  - conv_556
ER  - 
@article{
author = "Mihajlović, Marija and Mitrašinović, Petar M.",
year = "2009",
abstract = "Using the crystal structures of inhibitors bound to either group-2 or group-1 neuraminidases (NAs), AScore/ShapeDock (GaDock) scoring was shown to identify the binding modes in agreement with the experiment for all inhibitors docked in their own NA/inhibitor crystal structures. To investigate the effect of small changes in protein structure on predicted binding modes, in a set of 132 docking experiments (11 inhibitors docked in 12 group-2 NA structures), AScore/ShapeDock (GaDock) identified the correct binding modes of 116 complexes. In a total of 88 docking experiments (8 inhibitors docked in 11 group-1 NA structures), AScore/ShapeDock predicted 80 binding modes correctly. Flexible AScore/ShapeDock docking, as quite reproducible, is suggested to be convenient for designing novel H5N1 inhibitors.",
publisher = "Taylor & Francis Ltd, Abingdon",
journal = "Molecular Simulation",
title = "Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs)",
pages = "324-311",
number = "4",
volume = "35",
doi = "10.1080/08927020802430752",
url = "conv_556"
}
Mihajlović, M.,& Mitrašinović, P. M.. (2009). Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs). in Molecular Simulation
Taylor & Francis Ltd, Abingdon., 35(4), 311-324.
https://doi.org/10.1080/08927020802430752
conv_556
Mihajlović M, Mitrašinović PM. Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs). in Molecular Simulation. 2009;35(4):311-324.
doi:10.1080/08927020802430752
conv_556 .
Mihajlović, Marija, Mitrašinović, Petar M., "Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs)" in Molecular Simulation, 35, no. 4 (2009):311-324,
https://doi.org/10.1080/08927020802430752 .,
conv_556 .
25
25
29

Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)

Mihajlović, Marija; Mitrašinović, Petar M.

(Elsevier Science Bv, Amsterdam, 2008)

TY  - JOUR
AU  - Mihajlović, Marija
AU  - Mitrašinović, Petar M.
PY  - 2008
UR  - https://ritnms.itnms.ac.rs/handle/123456789/143
AB  - In the context of a recent pandemic threat by the worldwide spread of H5N1 avian influenza, the high resistance of H5N1 virus to the most widely used commercial drug, oseltarnivir (Tamiflu), is currently an important research topic. Herein, molecular bases of the mechanism of H5N1 NA resistance to orseltarnivir were elucidated using a computational approach in a systematic fashion. Using the crystal structure of the complex of H5N1 NAwith OTV (PDB ID: 2hu0) as the starting point, the question, how mutations at His274 by both smaller side chain (Gly, Set, Asn, Gln) and larger side chain (Phe, Tyr) residues influence the sensitivity of N1 to orseltarnivir, was addressed and correlated with the experimental data. The smaller side chain residue mutations of His;274 resulted in slightly enhanced or unchanged NA sensitivity to OTV, while His274Phe and His274Tyr reduced the susceptibility of OTV to N1. In contrast to the binding free energies, the net charges of Glu276 and Arg224, making charge-charge interactions with Glu276, were established to be more sensitive to detecting subtle conformational differences induced at the key residue Glu276 by the His274X mutations. This study provides deeper insights into the possibility of developing viable drug-resistant mutants.
PB  - Elsevier Science Bv, Amsterdam
T2  - Biophysical Chemistry
T1  - Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)
EP  - 158
IS  - 2-3
SP  - 152
VL  - 136
DO  - 10.1016/j.bpc.2008.06.003
UR  - conv_546
ER  - 
@article{
author = "Mihajlović, Marija and Mitrašinović, Petar M.",
year = "2008",
abstract = "In the context of a recent pandemic threat by the worldwide spread of H5N1 avian influenza, the high resistance of H5N1 virus to the most widely used commercial drug, oseltarnivir (Tamiflu), is currently an important research topic. Herein, molecular bases of the mechanism of H5N1 NA resistance to orseltarnivir were elucidated using a computational approach in a systematic fashion. Using the crystal structure of the complex of H5N1 NAwith OTV (PDB ID: 2hu0) as the starting point, the question, how mutations at His274 by both smaller side chain (Gly, Set, Asn, Gln) and larger side chain (Phe, Tyr) residues influence the sensitivity of N1 to orseltarnivir, was addressed and correlated with the experimental data. The smaller side chain residue mutations of His;274 resulted in slightly enhanced or unchanged NA sensitivity to OTV, while His274Phe and His274Tyr reduced the susceptibility of OTV to N1. In contrast to the binding free energies, the net charges of Glu276 and Arg224, making charge-charge interactions with Glu276, were established to be more sensitive to detecting subtle conformational differences induced at the key residue Glu276 by the His274X mutations. This study provides deeper insights into the possibility of developing viable drug-resistant mutants.",
publisher = "Elsevier Science Bv, Amsterdam",
journal = "Biophysical Chemistry",
title = "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)",
pages = "158-152",
number = "2-3",
volume = "136",
doi = "10.1016/j.bpc.2008.06.003",
url = "conv_546"
}
Mihajlović, M.,& Mitrašinović, P. M.. (2008). Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV). in Biophysical Chemistry
Elsevier Science Bv, Amsterdam., 136(2-3), 152-158.
https://doi.org/10.1016/j.bpc.2008.06.003
conv_546
Mihajlović M, Mitrašinović PM. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV). in Biophysical Chemistry. 2008;136(2-3):152-158.
doi:10.1016/j.bpc.2008.06.003
conv_546 .
Mihajlović, Marija, Mitrašinović, Petar M., "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)" in Biophysical Chemistry, 136, no. 2-3 (2008):152-158,
https://doi.org/10.1016/j.bpc.2008.06.003 .,
conv_546 .
22
23
27

Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework

Mitrašinović, Petar M.; Mihajlović, Marija

(Bentham Science Publ Ltd, Sharjah, 2008)

TY  - JOUR
AU  - Mitrašinović, Petar M.
AU  - Mihajlović, Marija
PY  - 2008
UR  - https://ritnms.itnms.ac.rs/handle/123456789/139
AB  - Due to rapid emergence of recombinant and antibody-based reagents targeting specifically biomarkers of disease, radiolabeling of antibodies has enabled the imaging and therapy of various reactive oxygen species (ROS)-mediated pathological conditions, such as cancer. Key contributions to this topic have been dissected through two main standpoints: (1) immunotherapeutics for advanced cancer care, including radiolabeling for cancer imaging and therapy, design and testing of antibodies, and radioimmunotherapy innovations for treating malignancies and (2) search for a more efficient drug-targeted delivery method for cancer therapy. Because tremendous progress has been made in recent years, the future of cancer radioimmunotherapy is suggested to be bright. The question, whether measurement of oxidative damage to DNA has clinical relevance, is addressed. To make biomarkers of oxidatively damaged DNA useful clinical tools, further validation of biomarkers, followed by further elucidation of the role of damage in disease, is suggested. To understand the role of oxidative damage by focusing on cellular processes under oxidative stress conditions, the complementarities of mechanistic cell biology studies and systems biology strategies in identifying new therapeutic targets are demonstrated for liver cancer cells. Since most morphological, physiological and molecular studies on death of cells in tissues have been carried out on isolated cell populations, systems biology is suggested to be a means of overcoming known difficulties manifested by interference and interaction with surrounding cells. The elucidation of fundamental background of the ability of cells to interpret the same signal action in distinct fashions - survival vs. death signal transduction is suggested to facilitate more localized and efficient treatments of various ROS-mediated pathologies.
PB  - Bentham Science Publ Ltd, Sharjah
T2  - Current Radiopharmaceuticals
T1  - Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework
EP  - 29
IS  - 1
SP  - 22
VL  - 1
DO  - 10.2174/1874471010801010022
UR  - conv_475
ER  - 
@article{
author = "Mitrašinović, Petar M. and Mihajlović, Marija",
year = "2008",
abstract = "Due to rapid emergence of recombinant and antibody-based reagents targeting specifically biomarkers of disease, radiolabeling of antibodies has enabled the imaging and therapy of various reactive oxygen species (ROS)-mediated pathological conditions, such as cancer. Key contributions to this topic have been dissected through two main standpoints: (1) immunotherapeutics for advanced cancer care, including radiolabeling for cancer imaging and therapy, design and testing of antibodies, and radioimmunotherapy innovations for treating malignancies and (2) search for a more efficient drug-targeted delivery method for cancer therapy. Because tremendous progress has been made in recent years, the future of cancer radioimmunotherapy is suggested to be bright. The question, whether measurement of oxidative damage to DNA has clinical relevance, is addressed. To make biomarkers of oxidatively damaged DNA useful clinical tools, further validation of biomarkers, followed by further elucidation of the role of damage in disease, is suggested. To understand the role of oxidative damage by focusing on cellular processes under oxidative stress conditions, the complementarities of mechanistic cell biology studies and systems biology strategies in identifying new therapeutic targets are demonstrated for liver cancer cells. Since most morphological, physiological and molecular studies on death of cells in tissues have been carried out on isolated cell populations, systems biology is suggested to be a means of overcoming known difficulties manifested by interference and interaction with surrounding cells. The elucidation of fundamental background of the ability of cells to interpret the same signal action in distinct fashions - survival vs. death signal transduction is suggested to facilitate more localized and efficient treatments of various ROS-mediated pathologies.",
publisher = "Bentham Science Publ Ltd, Sharjah",
journal = "Current Radiopharmaceuticals",
title = "Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework",
pages = "29-22",
number = "1",
volume = "1",
doi = "10.2174/1874471010801010022",
url = "conv_475"
}
Mitrašinović, P. M.,& Mihajlović, M.. (2008). Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework. in Current Radiopharmaceuticals
Bentham Science Publ Ltd, Sharjah., 1(1), 22-29.
https://doi.org/10.2174/1874471010801010022
conv_475
Mitrašinović PM, Mihajlović M. Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework. in Current Radiopharmaceuticals. 2008;1(1):22-29.
doi:10.2174/1874471010801010022
conv_475 .
Mitrašinović, Petar M., Mihajlović, Marija, "Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework" in Current Radiopharmaceuticals, 1, no. 1 (2008):22-29,
https://doi.org/10.2174/1874471010801010022 .,
conv_475 .
5

Molecular design of a crystal surface

Mihajlović, Marija; Mitrašinović, Petar M.

(Amer Chemical Soc, Washington, 2007)

TY  - CONF
AU  - Mihajlović, Marija
AU  - Mitrašinović, Petar M.
PY  - 2007
UR  - https://ritnms.itnms.ac.rs/handle/123456789/112
PB  - Amer Chemical Soc, Washington
C3  - Abstracts of Papers of the American Chemical Society
T1  - Molecular design of a crystal surface
VL  - 234
UR  - conv_473
ER  - 
@conference{
author = "Mihajlović, Marija and Mitrašinović, Petar M.",
year = "2007",
publisher = "Amer Chemical Soc, Washington",
journal = "Abstracts of Papers of the American Chemical Society",
title = "Molecular design of a crystal surface",
volume = "234",
url = "conv_473"
}
Mihajlović, M.,& Mitrašinović, P. M.. (2007). Molecular design of a crystal surface. in Abstracts of Papers of the American Chemical Society
Amer Chemical Soc, Washington., 234.
conv_473
Mihajlović M, Mitrašinović PM. Molecular design of a crystal surface. in Abstracts of Papers of the American Chemical Society. 2007;234.
conv_473 .
Mihajlović, Marija, Mitrašinović, Petar M., "Molecular design of a crystal surface" in Abstracts of Papers of the American Chemical Society, 234 (2007),
conv_473 .